“An anti-cancer shield created for each patient”
“Les Echos” is a French daily newspaper for economic and financial information, it defends an editorial line favorable to the market economy, open to the world and Europe.
In this paper : Brenus Story telling & closing of first financing round (€4M). Added value of Brenus compared to other treatmenst. STC technology will be at least 10 times less expensive than current CAR-T therapies. The goal is to be
administered in the first line of treatments with existing chemotherapy treatments.